Want to see HK:0557 full AI Analyst Report?
0557 Stock Chart & Stats
HK$0.60
-HK$0.07(-10.45%)
At close: 4:00 PM EDT
HK$0.60
-HK$0.07(-10.45%)
Day’s Range― - ―
52-Week RangeHK$0.07 - HK$0.95
Previous CloseN/A
Volume374.00K
Average Volume (3M)3.33K
Market Cap
HK$223.43M
Enterprise ValueHK$282.29M
Total Cash (Recent Filing)HK$29.51M
Total Debt (Recent Filing)HK$38.72M
Price to Earnings (P/E)―
Beta-0.77
Next Earnings
Aug 31, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.08
Shares Outstanding398,979,520
10 Day Avg. Volume1,000
30 Day Avg. Volume3,326
Financial Highlights & Ratios
PEG Ratio14.08
Price to Book (P/B)1.73
Price to Sales (P/S)14.56
P/FCF Ratio30.63
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
High Gross MarginsSustained gross margins above ~50% indicate the core distribution business retains healthy unit economics and pricing power. This margin buffer is a durable strength: if revenue stabilizes, it can absorb SG&A and support a path to operating breakeven without requiring radical price changes.
Manageable LeverageA low debt-to-equity ratio (~0.20–0.24) gives the company financial flexibility and lowers solvency risk. This conservative capital structure supports resilience through revenue volatility, reduces interest burden, and preserves optionality for modest investment or restructuring over the next several months.
Positive Operating & Free Cash FlowConsistent positive operating and free cash flow in 2023–2025, with FCF improvement in 2025, demonstrates the business can generate cash despite accounting losses. Durable cash generation helps fund working capital and reduces acute financing needs, giving management time to address structural profitability.
Bears Say
Sharp Revenue ContractionA multi-year top-line decline (≈27% in 2025) erodes scale, reduces operating leverage, and weakens market position. Persistent revenue loss makes fixed-cost absorption harder and limits the ability to invest in distribution or customer retention, posing a durable headwind unless growth reverses.
Sustained Operating LossesConsistent negative EBIT and EBITDA mean the company cannot currently convert gross margins into operating profit. This structural operating shortfall will continue to pressure equity and cash unless management materially cuts costs, raises revenue, or reconfigures the business model.
Eroding Equity & Negative ROEDeclining equity and ROE near -21% signal ongoing shareholder value erosion and weakened balance sheet capacity. Over months this reduces the firm’s ability to raise capital on favorable terms, constrains strategic options, and magnifies the impact of continued losses on solvency metrics.
China Tian Yuan Healthcare Group Limited News
0557 FAQ
What was China Tian Yuan Healthcare Group Limited’s price range in the past 12 months?
China Tian Yuan Healthcare Group Limited lowest stock price was HK$0.07 and its highest was HK$0.95 in the past 12 months.
What is China Tian Yuan Healthcare Group Limited’s market cap?
China Tian Yuan Healthcare Group Limited’s market cap is HK$223.43M.
When is China Tian Yuan Healthcare Group Limited’s upcoming earnings report date?
China Tian Yuan Healthcare Group Limited’s upcoming earnings report date is Aug 31, 2026 which is in 24 days.
How were China Tian Yuan Healthcare Group Limited’s earnings last quarter?
China Tian Yuan Healthcare Group Limited released its earnings results on Mar 30, 2026. The company reported -HK$0.078 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.078.
Is China Tian Yuan Healthcare Group Limited overvalued?
According to Wall Street analysts China Tian Yuan Healthcare Group Limited’s price is currently Overvalued.
Does China Tian Yuan Healthcare Group Limited pay dividends?
China Tian Yuan Healthcare Group Limited does not currently pay dividends.
What is China Tian Yuan Healthcare Group Limited’s EPS estimate?
China Tian Yuan Healthcare Group Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does China Tian Yuan Healthcare Group Limited have?
China Tian Yuan Healthcare Group Limited has 398,979,520 shares outstanding.
What happened to China Tian Yuan Healthcare Group Limited’s price movement after its last earnings report?
China Tian Yuan Healthcare Group Limited reported an EPS of -HK$0.078 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of China Tian Yuan Healthcare Group Limited?
Currently, no hedge funds are holding shares in HK:0557
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
China Tian Yuan Healthcare Group Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
37.93%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-13.78%
Trailing 12-Months
Company Description
China Tian Yuan Healthcare Group Limited
null
Technical Analysis
Keck Seng Investments (Hong Kong)
―
Langham Hospitality Investments
―
Magnificent Hotel Investments Limited
―
Sino Hotels (Holdings) Ltd.
―
Regal Hotels International Holdings Limited
―